z-logo
open-access-imgOpen Access
Reply to Ngene et al. (2013): Uterotonic agents should be avoided during cesarean hysterectomy for placenta previa accreta until evidence is forthcoming
Author(s) -
Matsubara Shigeki
Publication year - 2013
Publication title -
acta obstetricia et gynecologica scandinavica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.401
H-Index - 102
eISSN - 1600-0412
pISSN - 0001-6349
DOI - 10.1111/aogs.12227
Subject(s) - medicine , uterotonic , placenta accreta , placenta previa , obstetrics , hysterectomy , placenta , misoprostol , placenta percreta , gynecology , pregnancy , oxytocin , fetus , surgery , abortion , biology , genetics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here